Shares of Sequenom Inc. jumped Tuesday as a Cantor Fitzgerald analyst boosted her rating on the company, citing settlement of a recent lawsuit and progress in the diagnostic test maker’s pipeline of products.
The stock surged $1.51, or 21.8 percent, to $8.43 in afternoon trading. Shares have traded between $2.55 and $16.80 over the last 52 weeks.
SQNM FREE Report Shows – Strong Uptrend with money management stops. A triangle indicates the presence of a very strong trend that is being driven by strong forces and insiders.
Price target $12.00 near term
FREE SQNM Stock Analysis Sent To Your In-box By Clicking Here – Looks Like A Buy At These levels
